LYMPHOCYTE-MACROPHAGE ALVEOLITIS IN NONSMOKING INDIVIDUALS OCCUPATIONALLY EXPOSED TO ASBESTOS

被引:27
作者
ROM, WN
TRAVIS, WD
机构
[1] NYU,BELLEVUE HOSP CTR,MED CTR,DEPT ENVIRONM MED,NEW YORK,NY 10016
[2] NYU,BELLEVUE HOSP CTR,MED CTR,CHEST SERV,NEW YORK,NY 10016
[3] NCI,DIV CANC BIOL & PREVENT,PATHOL LAB,BETHESDA,MD 20892
基金
美国国家卫生研究院;
关键词
D O I
10.1378/chest.101.3.779
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A disordered immunologic activity has been observed in humans and animal models of asbestosis and silicosis. To characterize the lung immunologic response following long-term occupational exposure to asbestos, bronchoalveolar lavage (BAL) was performed on 28 nonsmoking individuals. Increased BAL lymphocytes were observed in one third. Lung lymphocytes were predominantly of the CD4+ helper-inducer subtype with increased CD4+/CD8+ ratio and increased surface expression of DR antigen consistent with the activation phenotype. Histologic evaluation of lung tissue from two individuals with lymphocytic-macrophage alveolitis and asbestos exposure revealed an infiltration of alveolar walls with chronic inflammatory mononuclear cells (lymphocytes). Interferon gamma was spontaneously released by BAL cells from 19 (76 percent) of 25 of the individuals with asbestos exposure and only one of ten normal controls. The release of interferon gamma by BAL cells could be further stimulated with concanavalin A and suppressed by cyclosporine. Although asbestosis is characterized by a predominant alveolar macrophage alveolitis, there is a subgroup with lymphocytic alveolitis and activated lymphocytes participating in the inflammatory response, especially in those without respiratory impairment early in the course of the disease process.
引用
收藏
页码:779 / 786
页数:8
相关论文
共 65 条
[1]  
ARENZANASEISDEDOS F, 1985, J IMMUNOL, V134, P2444
[2]  
BASHAM TY, 1983, J IMMUNOL, V130, P1492
[3]  
BATES DV, 1971, RESPIRATORY FUNCTION, P92
[4]   CLINICAL-FEATURES TO STAGE ALVEOLITIS IN ASBESTOS WORKERS [J].
BEGIN, R ;
CANTIN, A ;
BERTHIAUME, Y ;
BOILEAU, R ;
BISSON, G ;
LAMOUREUX, G ;
ROLAPLESZCZYNSKI, M ;
DRAPEAU, G ;
MASSE, S ;
BOCTOR, M ;
BREAULT, J ;
PELOQUIN, S ;
DALLE, D .
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1985, 8 (06) :521-536
[5]  
BOZELKA BE, 1983, AM J PATHOL, V112, P326
[6]   EFFECTS OF ASBESTOS FIBERS ON ALVEOLAR MACROPHAGE-MEDIATED LYMPHOCYTE CYTOSTASIS [J].
BOZELKA, BE ;
SESTINI, P ;
HAMMAD, Y ;
SALVAGGIO, JE .
ENVIRONMENTAL RESEARCH, 1986, 40 (01) :172-180
[7]   RAISED IMMUNOGLOBULIN CONCENTRATIONS IN BRONCHOALVEOLAR LAVAGE FLUID OF HEALTHY GRANITE WORKERS [J].
CALHOUN, WJ ;
CHRISTMAN, JW ;
ERSHLER, WB ;
GRAHAM, WGB ;
DAVIS, GS .
THORAX, 1986, 41 (04) :266-273
[8]  
CAMPBELL MJ, 1980, CLIN EXP IMMUNOL, V39, P176
[9]   TUMOR NECROSIS FACTOR AND IMMUNE INTERFERON SYNERGISTICALLY INDUCE CYTOCHROME-B-245 HEAVY-CHAIN GENE-EXPRESSION AND NICOTINAMIDE-ADENINE DINUCLEOTIDE PHOSPHATE HYDROGENASE OXIDASE IN HUMAN-LEUKEMIC MYELOID CELLS [J].
CASSATELLA, MA ;
HARTMAN, L ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1570-1579
[10]   EVIDENCE FOR A GAMMA-INTERFERON RECEPTOR THAT REGULATES MACROPHAGE TUMORICIDAL ACTIVITY [J].
CELADA, A ;
GRAY, PW ;
RINDERKNECHT, E ;
SCHREIBER, RD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) :55-74